Your browser doesn't support javascript.
loading
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
Sandborn, William J; Ferrante, Marc; Bhandari, Bal R; Berliba, Elina; Hibi, Toshifumi; D'Haens, Geert R; Tuttle, Jay L; Krueger, Kathryn; Friedrich, Stuart; Durante, Michael; Arora, Vipin; Naegeli, April N; Schmitz, Jochen; Feagan, Brian G.
Afiliación
  • Sandborn WJ; University of California San Diego, La Jolla, California. Electronic address: wsandborn@ucsd.edu.
  • Ferrante M; Universitair Ziekenhuizen Leuven, Leuven, Belgium.
  • Bhandari BR; Delta Research Partners, Bastrop, Louisiana.
  • Berliba E; Arsenia EM, Chisinau, Moldova (the Republic of), Tokyo, Japan.
  • Hibi T; Kitasato Institute Hospital Center for Advanced IBD Research and Treatment, Minato-ku, Tokyo, Japan.
  • D'Haens GR; Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Tuttle JL; Eli Lilly and Company, Indianapolis, Indiana.
  • Krueger K; Eli Lilly and Company, Indianapolis, Indiana.
  • Friedrich S; Eli Lilly and Company, Indianapolis, Indiana.
  • Durante M; Eli Lilly and Company, Indianapolis, Indiana.
  • Arora V; Eli Lilly and Company, Indianapolis, Indiana.
  • Naegeli AN; Eli Lilly and Company, Indianapolis, Indiana.
  • Schmitz J; Eli Lilly and Company, Indianapolis, Indiana.
  • Feagan BG; Western University, Robarts Clinical Trials Inc, London, ON, Canada.
Clin Gastroenterol Hepatol ; 20(1): 105-115.e14, 2022 01.
Article en En | MEDLINE | ID: mdl-32950748
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article